等待开盘 11-18 09:30:00 美东时间
0.000
0.00%
Keke's Breakfast Cafe offers a Black Friday through Cyber Monday deal: Buy $50 e-gift card, get an additional $50 online. Available November 27–30, this promotion allows customers to share the joy of a freshly made meal with family and friends. The e-gift cards can be used for breakfast favorites like pancakes, waffles, and eggs. Additionally, a $10 bonus is available for $50 e-gift card purchases through December 24. Keke's provides dine-in, pic...
11-17 15:14
The latest update is out from Metropal Kurumsal Hizmetler A.S. ( ($TR:MCARD) )....
11-13 23:59
Metropal Kurumsal Hizmetler A.S. ( ($TR:MCARD) ) has shared an announcement. Me...
11-13 23:57
Metropal Kurumsal Hizmetler A.S. ( ($TR:MCARD) ) has provided an update. Metrop...
11-12 01:14
Milestone Pharmaceuticals Inc. granted 33,000 stock options to a new employee under its 2021 Inducement Plan. The options have a grant date of November 2, 2026, with an exercise price of $0.72 per share, vesting over four years. The Plan is used to incentivize new hires, in compliance with Nasdaq Listing Rule 5635(c)(4). Milestone is a biopharmaceutical company focused on developing cardiovascular medicines, with its lead product CARDAMYST® (etri...
11-04 01:45
The latest update is out from Metropal Kurumsal Hizmetler A.S. ( ($TR:MCARD) )....
11-03 23:17
The latest update is out from Metropal Kurumsal Hizmetler A.S. ( ($TR:MCARD) )....
11-02 15:58
Milestone Pharmaceuticals announced new data showing that CARDAMYST® (etripamil) nasal spray successfully converted approximately two-thirds of patients with recurrent PSVT after prior catheter ablation to normal heart rhythm within 30 minutes. This subgroup analysis from the Phase 3 RAPID trial highlights the potential of etripamil as a self-administered treatment option for patients with persistent PSVT following ablation. The findings reinforc...
11-02 13:00
• FDA granted accelerated approval for Ultomiris to treat primary IgA nephropathy. • AstraZeneca reports annual revenue of $58.74B and net profit of $10.22B. • Analysts issued Buy ratings with an average price target of $210.32.
10-22 18:15
Metropal Kurumsal Hizmetler A.S. ( ($TR:MCARD) ) has shared an announcement. Me...
10-21 22:13